P. Masel

1.1k total citations
20 papers, 195 citations indexed

About

P. Masel is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, P. Masel has authored 20 papers receiving a total of 195 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 4 papers in Physiology and 3 papers in Surgery. Recurrent topics in P. Masel's work include Cystic Fibrosis Research Advances (5 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers) and Respiratory and Cough-Related Research (3 papers). P. Masel is often cited by papers focused on Cystic Fibrosis Research Advances (5 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers) and Respiratory and Cough-Related Research (3 papers). P. Masel collaborates with scholars based in Australia, United Kingdom and India. P. Masel's co-authors include Scott C. Bell, Luke Garske, Ian A. Yang, Ren‐You Gan, Christopher Coulter, Timothy J. Kidd, Kwun M. Fong, Rayleen Bowman, D.J. Hendrick and S. McKenzie and has published in prestigious journals such as SHILAP Revista de lepidopterología, BMJ Open and Journal of Hospital Infection.

In The Last Decade

P. Masel

18 papers receiving 189 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Masel Australia 8 142 39 29 27 24 20 195
Adrienne P. Savant United States 8 107 0.8× 23 0.6× 7 0.2× 11 0.4× 20 0.8× 26 194
Emilia Barrot Cortés Spain 9 122 0.9× 104 2.7× 41 1.4× 36 1.3× 40 1.7× 22 320
Wynton Hoover United States 8 105 0.7× 30 0.8× 38 1.3× 37 1.4× 12 0.5× 11 166
Rahul Magazine India 10 117 0.8× 43 1.1× 12 0.4× 16 0.6× 68 2.8× 49 261
Sujeet Rajan India 7 89 0.6× 52 1.3× 62 2.1× 11 0.4× 49 2.0× 20 192
Lucile Regard France 10 145 1.0× 29 0.7× 22 0.8× 18 0.7× 27 1.1× 17 233
Naohiko Chohnabayashi Japan 8 154 1.1× 65 1.7× 16 0.6× 14 0.5× 49 2.0× 37 282
Francesco Paravati Italy 8 64 0.5× 19 0.5× 22 0.8× 27 1.0× 63 2.6× 14 173
Marta Bassi Italy 9 34 0.2× 10 0.3× 32 1.1× 36 1.3× 17 0.7× 34 253
Lee‐Won Chong Taiwan 7 45 0.3× 14 0.4× 29 1.0× 12 0.4× 20 0.8× 13 181

Countries citing papers authored by P. Masel

Since Specialization
Citations

This map shows the geographic impact of P. Masel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Masel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Masel more than expected).

Fields of papers citing papers by P. Masel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Masel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Masel. The network helps show where P. Masel may publish in the future.

Co-authorship network of co-authors of P. Masel

This figure shows the co-authorship network connecting the top 25 collaborators of P. Masel. A scholar is included among the top collaborators of P. Masel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Masel. P. Masel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnson, Elizabeth M., Daniel B. Smith, Daniel Henderson, et al.. (2025). Disproportionate Rates of Liver Injury in People With Cystic Fibrosis on Elexacaftor/Tezacaftor/Ivacaftor in Queensland, Australia. Gastro Hep Advances. 4(6). 100641–100641.
2.
Kumar, S., Daniel J. Smith, P. Masel, et al.. (2023). Paraquat ingestion in an adult with cystic fibrosis (CF): Diagnostic and management dilemmas. SHILAP Revista de lepidopterología. 11(12). e01235–e01235. 1 indexed citations
3.
Tippett, Vivienne, Rayleen Bowman, Kwun M. Fong, et al.. (2022). The clinical journey of patients with a severe exacerbation of chronic obstructive pulmonary disease (COPD): from the ambulance to the emergency department to the hospital ward. Journal of Thoracic Disease. 14(12). 4601–4613. 1 indexed citations
4.
Chambers, Daniel C., et al.. (2021). Radiological outcomes of whole lung lavage for artificial stone‐associated silicosis. Respirology. 26(5). 501–503. 13 indexed citations
5.
Tippett, Vivienne, Rayleen Bowman, Kwun M. Fong, et al.. (2019). Exacerbations of chronic obstructive pulmonary disease (COPD) require frequent ambulance and emergency department management in Queensland. Respirology. 24. 132–132.
6.
Ding, Hang, Mohan Karunanithi, Lisa K McCarthy, et al.. (2019). Evaluation of an innovative mobile health programme for the self-management of chronic obstructive pulmonary disease (MH-COPD): protocol of a randomised controlled trial. BMJ Open. 9(4). e025381–e025381. 14 indexed citations
7.
Masel, P., Michael Hamilton, Kwun M. Fong, et al.. (2019). Diagnostic approach to chronic dyspnoea in adults. Journal of Thoracic Disease. 11(S17). S2117–S2128. 18 indexed citations
8.
McKenzie, S., Rayleen Bowman, Michael Hamilton, et al.. (2018). Diagnosis of the cause of chronic dyspnoea in primary and tertiary care: characterizing diagnostic confidence. Journal of Thoracic Disease. 10(6). 3745–3756. 6 indexed citations
9.
Kudo, Masataka, et al.. (2016). Utility of thrombophilia testing in patients with venous thrombo-embolism. Journal of Thoracic Disease. 8(12). 3697–3703. 10 indexed citations
10.
Gupta, Ajay, et al.. (2016). Transtuzumab induced organizing pneumonia: a case report. SpringerPlus. 5(1). 1964–1964. 4 indexed citations
11.
Henderson, Robert D., et al.. (2016). Adult‐onset Pompe's disease presenting with insidious hypercapnic respiratory failure. Respirology Case Reports. 4(5). e00178–e00178. 1 indexed citations
12.
Masel, P., et al.. (2015). Complexity of Nutrition Screening in Patients Admitted with An Exacerbation of Chronic Obstructive Pulmonary Disease (Copd). Respirology. 20. 103–103. 1 indexed citations
13.
Masel, P., et al.. (2015). Results of a clinical audit on drug‐related problems identified by a clinical pharmacist in a thoracic outpatient clinic. Journal of Pharmacy Practice and Research. 45(1). 31–37. 1 indexed citations
14.
Wood, Michelle, et al.. (2013). Ivacaftor in severe cystic fibrosis lung disease and a G 551 D mutation. Respirology Case Reports. 1(2). 52–54. 6 indexed citations
15.
Masel, P.. (2012). Management of cystic fibrosis in adults. Australian Prescriber. 35(4). 118–121. 1 indexed citations
16.
Smith, Daniel J., David W. Reid, R. Slaughter, et al.. (2011). Superior vena cava obstruction due to total implantable venous access devices in cystic fibrosis: Case series and review. Respiratory Medicine CME. 4(3). 99–104. 1 indexed citations
17.
Masel, P., et al.. (2010). The month of July: an early experience with pandemic influenza A (H1N1) in adults with cystic fibrosis. BMC Pulmonary Medicine. 10(1). 8–8. 14 indexed citations
18.
Garske, Luke, Timothy J. Kidd, Ren‐You Gan, et al.. (2004). Rifampicin and sodium fusidate reduces the frequency of methicillin-resistant Staphylococcus aureus (MRSA) isolation in adults with cystic fibrosis and chronic MRSA infection. Journal of Hospital Infection. 56(3). 208–214. 56 indexed citations
19.
Askew, Judah, et al.. (2004). Relation of expired carbon monoxide to smoking history, lapsed time, TLCO measurement and passive smoking. Respiratory Medicine. 99(1). 32–38. 13 indexed citations
20.
Masel, P., et al.. (2002). Nebulised dornase alpha: adherence in adults with cystic fibrosis. Journal of Cystic Fibrosis. 1(4). 255–259. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026